• Anon (2010) New Focus Area: Implementation and Operational Research. Journal of Acquired Immune Deficiency Syndromes 54 4, 339.
  • Dondorp AM, Fanello CI, Hendriksen IC et al. (2010) Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet 376, 16471657.
  • Ehrhardt S & Meyer CG (2012) Transfer of evidence-based medical guidelines to low- and middle-income countries. Tropical Medicine & International Health 17, 144146.
  • Ford NP, de Smet M, Kolappa K & White NJ (2011) Responding to the evidence for the management of severe malaria. Tropical Medicine & International Health 16, 10851086.
  • Guyatt GH, Oxman AD, Vist G et al. (2011a) GRADE guidelines: 4. Rating the quality of evidence–study limitations (risk of bias). Journal of Clinical Epidemiology 64, 407415.
  • Guyatt GH, Oxman AD, Sultan S et al. (2011b) GRADE guidelines: 9. Rating up the quality of evidence. Journal of Clinical Epidemiology 64, 13111316.
  • Maher D, Harries AD, Nachega JB & Jaffar S (2012) Methodology matters: what type of research is suitable for evaluating community treatment supporters for HIV and tuberculosis treatment? Tropical Medicine & International Health 17, 264271.
  • Maitland K, Kiguli S, Opoka RO et al. (2011) Mortality after fluid bolus in African children with severe infection. New England Journal of Medicine, 364, 24832495.
  • Njeuhmeli E, Forsythe S, Reed J et al. (2011) Voluntary medical male circumcision: modeling the impact and cost of expanding male circumcision for HIV prevention in eastern and southern Africa. PLOS Medicine 8, e1001132.
  • Rawlins M (2008) De testimonio: on the evidence for decisions about the use of therapeutic interventions. Lancet 372, 21522161.
  • Siegfried N, Muller M, Deeks JJ & Volmink J (2009) Male circumcision for prevention of heterosexual acquisition of HIV in men. Cochrane Database Systematic Review 15, CD003362.
  • Zachariah R, Ford N, Maher D et al. (2012) Is operational research delivering the goods? The journey to success in low-income countries. The Lancet Infectious Diseases 12, 415421.